Received Feb 17, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | 4 | M4ZE7 | IM / LL |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | GP759l | IM / RL |
| HIBV | HIB (ACTHIB) | SANOFI PASTEUR | 4 | UK372AB | IM / LL |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | Z005569 | SC / RL |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 4 | MH1445 | IM / RL |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Z011893 | SC / LL |
During PCV20 attempted administration, patient moved. Neele entered the skin x 2 without medication administration. Administration completed with new PCV20 dose.
Office visit on 1/6/2026 for petechiae rash around eyes and behind left ear, bilateral eye discharge, and rash on back (heat rash vs irritant dermatitis). Office visit on 1/13/2026 for follow up--rash and eye discharge resolved. Office visit for 12 mo WCC on 2/3/2026.
Trisomy 21; Congenital laryngomalacia; GERD (gastroesophageal reflux disease); Congenital nystagmus; and Other dysphagia
None
No known allergies
None ordered.